These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2468413)

  • 21. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall.
    Vecchiarelli A; Puliti M; Torosantucci A; Cassone A; Bistoni F
    Cell Immunol; 1991 Apr; 134(1):65-76. PubMed ID: 1672836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphokine-activated killer cells in mouse bone marrow chimaeras. The relationship to natural killer cells and to alloreactive cytotoxic T cells.
    Sihvola M
    Scand J Immunol; 1985 Nov; 22(5):479-88. PubMed ID: 2867599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AGM1+ spleen cells contain gamma interferon (IFN-gamma) gene transcripts in the early, sex-dependent production of IFN-gamma after picornavirus infection.
    McFarland HI; Bigley NJ
    J Virol; 1990 Sep; 64(9):4407-13. PubMed ID: 1974653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
    Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR
    J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.
    Lauwerys BR; Garot N; Renauld JC; Houssiau FA
    J Immunol; 2000 Aug; 165(4):1847-53. PubMed ID: 10925263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
    Yoshioka T; Sato S; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen and antiestrogen modulation of the levels of mouse natural killer activity and large granular lymphocytes.
    Screpanti I; Santoni A; Gulino A; Herberman RB; Frati L
    Cell Immunol; 1987 May; 106(2):191-202. PubMed ID: 2882860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxicity of cultured mouse spleen cells against natural killer-sensitive target cells. Characterization of the effector cells.
    Oshimi K; Kano S; Sumiya M; Gonda N; Takaku F
    Int Arch Allergy Appl Immunol; 1981; 64(4):395-409. PubMed ID: 6451584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of natural killer cells in the mechanism of the antitumor effect of interferon on Moloney sarcoma virus-transformed cells.
    Fresa KL; Murasko DM
    Cancer Res; 1986 Jan; 46(1):81-8. PubMed ID: 3940213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous interferon alpha/beta produced by Kupffer cells inhibits interleukin-1, tumor necrosis factor alpha production and interleukin-2-induced activation of nonparenchymal liver cells.
    Tzung SP; Cohen SA
    Cancer Immunol Immunother; 1991; 34(3):150-6. PubMed ID: 1756531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural killer (NK) cell activating factor released from murine thymocytes stimulated with an anti-tumor streptococcal preparation, OK-432.
    Shitara K; Ichimura O; Mitsuno T; Osawa T
    J Immunol; 1985 Feb; 134(2):1039-47. PubMed ID: 2578148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell and interferon-gamma involvement in the adjuvant action of a detoxified endotoxin.
    Tomai MA; Johnson AG
    J Biol Response Mod; 1989 Dec; 8(6):625-43. PubMed ID: 2513379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of cytotoxic cells generated from in vitro cultures of murine bone marrow cells.
    Klimpel GR; Sarzotti M; Reyes VE; Klimpel KD
    Cell Immunol; 1985 Apr; 92(1):1-13. PubMed ID: 2416478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of murine B cell Thy-1 expression by IL-4, IFN-gamma, and CD4+ T cell subsets.
    Snapper CM
    Cell Immunol; 1990 Aug; 129(1):80-94. PubMed ID: 1973079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asialo-GM1-positive T killer cells are generated in F1 mice injected with parental spleen cells.
    Knobloch C; Dennert G
    J Immunol; 1988 Feb; 140(3):744-9. PubMed ID: 2448375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer (NK) cells and graft-versus-host disease (GVHD): no correlation between the NK cell levels and GVHD in the murine P----F1 model.
    Varkila K; Hurme M
    Immunology; 1985 Jan; 54(1):121-6. PubMed ID: 3972429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmentation of murine lymphokine-activated killer cell induction by a factor produced by Nocardia rubra cell wall skeleton-stimulated T cells.
    Kawase I; Shirasaka T; Ikeda T; Hara H; Tanio Y; Watanabe M; Saito S; Masuno T; Kishimoto S; Yamamura Y
    Jpn J Cancer Res; 1989 Nov; 80(11):1098-105. PubMed ID: 2481664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.